Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - Han, J K; Bachert, C; Fokkens, W (Lancet Respir Med, 2021)
et al.